AXVYLA

pharmaceutical preparations for treating metabolic disorders; pharmaceutical preparations for treating fibrotic disorders; pharmaceutical preparations for treating mitochondrial disease; pharmaceutical preparations for treating NAFLD and NASH disease; pharmaceutical preparations for treating liver diseases and disorders; pharmaceuticals for treating genetic disorders; pharmaceuticals for treating neurological disorders; and pharmaceuticals for treating Huntington's disease; pharmaceutical preparations for treating neurodegenerative diseases and disorders; pharmaceutical preparations for treating lung infections; pharmaceutical preparations for treating cancer